Russian developers have registered a new drug that may help alleviate the harshest complications caused by Covid-19, including lung failure. It’s hoped the treatment can buy time before a vaccine is found.
Levilimab is the second medication to receive state approval through a fast-track mechanism, implemented to give doctors more options to tackle the virus, which has already infected more than 459,000 and killed 5,725 in Russia, according to official statistics.
Continue reading https://on.rt.com/aiwq